应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GMED Globus Medical Inc
盘后交易 04-17 18:48:58 EDT
71.01
-0.13
-0.18%
盘后
70.25
-0.76
-1.07%
16:20 EDT
最高
71.80
最低
70.74
成交量
57.43万
今开
71.50
昨收
71.14
日振幅
1.49%
总市值
97.67亿
流通市值
81.11亿
总股本
1.38亿
成交额
4,085万
换手率
0.50%
流通股本
1.14亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
巴克莱:维持Globus Medical(GMED.US)评级,由增持调整至增持评级, 目标价由100.00美元调整至103.00美元。
金融界 · 02-24
巴克莱:维持Globus Medical(GMED.US)评级,由增持调整至增持评级, 目标价由100.00美元调整至103.00美元。
Globus Medical, Inc.2024财年实现净利润1.03亿美元,同比减少16.26%
市场透视 · 02-23
Globus Medical, Inc.2024财年实现净利润1.03亿美元,同比减少16.26%
Globus Medical, Inc.盘中异动 急速跳水5.08%
市场透视 · 02-21
Globus Medical, Inc.盘中异动 急速跳水5.08%
Stifel:维持Globus Medical(GMED.US)评级,由买入调整至买入评级, 目标价由92.00美元调整至94.00美元。
金融界 · 02-21
Stifel:维持Globus Medical(GMED.US)评级,由买入调整至买入评级, 目标价由92.00美元调整至94.00美元。
Needham:重申Globus Medical(GMED.US)评级,由持有调整至持有评级。
金融界 · 02-21
Needham:重申Globus Medical(GMED.US)评级,由持有调整至持有评级。
Globus Medical 2024年第四季度每股收益$0.84超出预期$0.75,销售额$6.5729亿超出预期$6.4179亿
财报速递 · 02-20
Globus Medical 2024年第四季度每股收益$0.84超出预期$0.75,销售额$6.5729亿超出预期$6.4179亿
Globus Medical, Inc.盘中异动 股价大跌5.23%报87.57美元
市场透视 · 02-06
Globus Medical, Inc.盘中异动 股价大跌5.23%报87.57美元
加拿大投资银行集团:维持Globus Medical(GMED.US)评级,由买入调整至买入评级, 目标价由92.00美元调整至101.00美元。
金融界 · 01-10
加拿大投资银行集团:维持Globus Medical(GMED.US)评级,由买入调整至买入评级, 目标价由92.00美元调整至101.00美元。
B of A Securities:上调Globus Medical(GMED.US)评级,由低于大市调整至中性评级, 目标价由80.00美元调整至97.00美元。
金融界 · 01-09
B of A Securities:上调Globus Medical(GMED.US)评级,由低于大市调整至中性评级, 目标价由80.00美元调整至97.00美元。
Globus Medical, Inc.2024财年第三财季实现净利润51.84百万美元,同比增加5094.39%
市场透视 · 2024-11-10
Globus Medical, Inc.2024财年第三财季实现净利润51.84百万美元,同比增加5094.39%
异动解读 | 骨科医疗器械商Globus Medical第三季度业绩亮眼 股价盘前大涨12%
异动解读 · 2024-11-06
异动解读 | 骨科医疗器械商Globus Medical第三季度业绩亮眼 股价盘前大涨12%
异动解读 | 医疗器械巨头Globus Medical第三季度业绩超预期 股价盘后大涨
异动解读 · 2024-11-06
异动解读 | 医疗器械巨头Globus Medical第三季度业绩超预期 股价盘后大涨
异动解读 | Globus Medical第三季度业绩超预期 全年指引上调 盘后股价大涨9.55%
异动解读 · 2024-11-06
异动解读 | Globus Medical第三季度业绩超预期 全年指引上调 盘后股价大涨9.55%
异动解读 | Globus Medical 2024第三季度业绩超预期,股价盘后大涨 10%
异动解读 · 2024-11-05
异动解读 | Globus Medical 2024第三季度业绩超预期,股价盘后大涨 10%
Globus Medical第三季度业绩强劲并上调指引,盘后股价上涨10%
老虎资讯综合 · 2024-11-05
Globus Medical第三季度业绩强劲并上调指引,盘后股价上涨10%
加载更多
公司概况
公司名称:
Globus Medical Inc
所属市场:
NYSE
上市日期:
--
主营业务:
Globus Medical, Inc.于2003年3月在特拉华州注册成立。作为一家医疗器械生产公司,Globus完全专注于其产品的设计、开发以及其商业化,其中这些产品能促进有脊柱疾病患者康复。Globus的产品分为两类,即创新融合类和颠覆性科技类。
发行价格:
--
{"stockData":{"symbol":"GMED","market":"US","secType":"STK","nameCN":"Globus Medical Inc","latestPrice":71.01,"timestamp":1744920000000,"preClose":71.14,"halted":0,"volume":574325,"hourTrading":{"tag":"盘后","latestPrice":70.25,"preClose":71.01,"latestTime":"16:20 EDT","volume":19549,"amount":1388173.043374,"timestamp":1744921238026},"delay":0,"floatShares":114216771,"shares":137541648,"eps":0.75,"marketStatus":"盘后交易","change":-0.13,"latestTime":"04-17 18:48:58 EDT","open":71.5,"high":71.8,"low":70.74,"amount":40850705.7623,"amplitude":0.0149,"askPrice":79.24,"askSize":100,"bidPrice":64.25,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.75,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1744934400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1343966400000,"exchange":"NYSE","adjPreClose":71.14,"preHourTrading":{"tag":"盘前","latestPrice":72.1,"preClose":71.14,"latestTime":"09:20 EDT","volume":807,"amount":58339.89417,"timestamp":1744896006807},"postHourTrading":{"tag":"盘后","latestPrice":70.25,"preClose":71.01,"latestTime":"16:20 EDT","volume":19549,"amount":1388173.043374,"timestamp":1744921238026},"volumeRatio":0.609296,"impliedVol":0.4194,"impliedVolPercentile":0.8566},"requestUrl":"/m/hq/s/GMED","defaultTab":"news","newsList":[{"id":"2513724117","title":"巴克莱:维持Globus Medical(GMED.US)评级,由增持调整至增持评级, 目标价由100.00美元调整至103.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513724117","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513724117?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:13","pubTimestamp":1740406420,"startTime":"0","endTime":"0","summary":"巴克莱:维持Globus Medical(GMED.US)评级,由增持调整至增持评级, 目标价由100.00美元调整至103.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24221348352761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GMED"],"gpt_icon":0},{"id":"2513756135","title":"Globus Medical, Inc.2024财年实现净利润1.03亿美元,同比减少16.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513756135","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513756135?lang=zh_cn&edition=full","pubTime":"2025-02-24 00:01","pubTimestamp":1740326492,"startTime":"0","endTime":"0","summary":"2月24日,Globus Medical, Inc.公布财报,公告显示公司2024财年净利润为1.03亿美元,同比减少16.26%;其中营业收入为25.19亿美元,同比增加60.65%,每股基本收益为0.76美元。从资产负债表来看,Globus Medical, Inc.总负债10.74亿美元,其中短期债务4.54亿美元,资产负债比为4.90,流动比率为2.55。机构评级:截至2025年2月24日,当前有13家机构对Globus Medical, Inc.目标价做出预测,其中目标均价为98.69美元,其中最低目标价为90.00美元,最高目标价为115.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000221a250ce41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000221a250ce41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GMED"],"gpt_icon":0},{"id":"2513135612","title":"Globus Medical, Inc.盘中异动 急速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513135612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513135612?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:29","pubTimestamp":1740158998,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时29分,Globus Medical, Inc.股票出现异动,股价急速下跌5.08%。Globus Medical, Inc.股票所在的医疗器械行业中,整体跌幅为0.27%。其相关个股中,Ainos Inc C/Wts 29/07/2027 、Sintx Technologies, Inc.、Intelligent Bio Solutions Inc.涨幅较大,Sintx Technologies, Inc.、Reshape Lifesciences, Inc.、沃氪医疗较为活跃,换手率分别为189.92%、42.27%、20.24%,振幅较大的相关个股有Ainos Inc C/Wts 29/07/2027 、Pavmed Inc C/Wts 30/04/2025 Class Z、Nexalin Technology Inc C/Wts ,振幅分别为89.61%、59.52%、30.77%。Globus Medical, Inc.公司简介:Globus Medical Inc是一家医疗设备公司,为医院、医生和外科中心开发并提供医疗保健产品和解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222012958962ba2c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222012958962ba2c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0009354923.USD","GMED","LU2065732104.USD","BK4082"],"gpt_icon":0},{"id":"2513529626","title":"Stifel:维持Globus Medical(GMED.US)评级,由买入调整至买入评级, 目标价由92.00美元调整至94.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513529626","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513529626?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:41","pubTimestamp":1740148867,"startTime":"0","endTime":"0","summary":"Stifel:维持Globus Medical(GMED.US)评级,由买入调整至买入评级, 目标价由92.00美元调整至94.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/21224148320217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GMED"],"gpt_icon":0},{"id":"2513642212","title":"Needham:重申Globus Medical(GMED.US)评级,由持有调整至持有评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513642212","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513642212?lang=zh_cn&edition=full","pubTime":"2025-02-21 20:27","pubTimestamp":1740140875,"startTime":"0","endTime":"0","summary":"Needham:重申Globus Medical(GMED.US)评级,由持有调整至持有评级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/21202748318257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GMED"],"gpt_icon":0},{"id":"1113698346","title":"Globus Medical 2024年第四季度每股收益$0.84超出预期$0.75,销售额$6.5729亿超出预期$6.4179亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1113698346","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113698346?lang=zh_cn&edition=full","pubTime":"2025-02-21 05:18","pubTimestamp":1740086330,"startTime":"0","endTime":"0","summary":"Globus Medical 报告季度每股收益为$0.84,超出分析师普遍预期的$0.75,超出12%。该公司报告季度销售额为$6.5729亿,超出分析师普遍预期的$6.4179亿,超出2.42%。与去年同期销售额$6.1653亿相比增长了6.61%。以上内容来自Benzinga Earnings专栏,原文如下:Globus Medical reported quarterly earnings of $0.84 per share which beat the analyst consensus estimate of $0.75 by 12 percent. This is a 40 percent increase over earnings of $0.60 per share from the same period last year. The company reported quarterly sales of $657.29 million which beat the analyst consensus estimate of $641.79 million ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Globus Medical 2024年第四季度每股收益$0.84超出预期$0.75,销售额$6.5729亿超出预期$6.4179亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GMED"],"gpt_icon":0},{"id":"2509272526","title":"Globus Medical, Inc.盘中异动 股价大跌5.23%报87.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509272526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509272526?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:31","pubTimestamp":1738852292,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时31分,Globus Medical, Inc.股票出现波动,股价急速下挫5.23%。截至发稿,该股报87.57美元/股,成交量3.8505万股,换手率0.03%,振幅2.37%。Globus Medical, Inc.股票所在的医疗器械行业中,整体跌幅为0.12%。Globus Medical, Inc.公司简介:Globus Medical Inc是一家医疗设备公司,为医院、医生和外科中心开发并提供医疗保健产品和解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223133a23bce20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223133a23bce20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","LU2065732104.USD","GMED","IE0009354923.USD"],"gpt_icon":0},{"id":"2502447893","title":"加拿大投资银行集团:维持Globus Medical(GMED.US)评级,由买入调整至买入评级, 目标价由92.00美元调整至101.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2502447893","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502447893?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:33","pubTimestamp":1736523183,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团:维持Globus Medical(GMED.US)评级,由买入调整至买入评级, 目标价由92.00美元调整至101.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/10233347360005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GMED"],"gpt_icon":0},{"id":"2502010979","title":"B of A Securities:上调Globus Medical(GMED.US)评级,由低于大市调整至中性评级, 目标价由80.00美元调整至97.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2502010979","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502010979?lang=zh_cn&edition=full","pubTime":"2025-01-09 22:02","pubTimestamp":1736431341,"startTime":"0","endTime":"0","summary":"B of A Securities:上调Globus Medical(GMED.US)评级,由低于大市调整至中性评级, 目标价由80.00美元调整至97.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/09220247318816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GMED"],"gpt_icon":0},{"id":"2482267891","title":"Globus Medical, Inc.2024财年第三财季实现净利润51.84百万美元,同比增加5094.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482267891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482267891?lang=zh_cn&edition=full","pubTime":"2024-11-11 00:01","pubTimestamp":1731254509,"startTime":"0","endTime":"0","summary":"11月11日,Globus Medical, Inc.公布财报,公告显示公司2024财年第三财季净利润为51.84百万美元,同比增加5094.39%;其中营业收入为6.26亿美元,同比增加63.02%,每股基本收益为0.38美元。从资产负债表来看,Globus Medical, Inc.总负债10.17亿美元,其中短期债务4.49亿美元,资产负债比为5.01,流动比率为2.52。机构评级:截至2024年11月11日,当前有13家机构对Globus Medical, Inc.目标价做出预测,其中目标均价为90.54美元,其中最低目标价为80.00美元,最高目标价为100.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000248abb363cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000248abb363cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GMED"],"gpt_icon":0},{"id":"1135819053","title":"异动解读 | 骨科医疗器械商Globus Medical第三季度业绩亮眼 股价盘前大涨12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135819053","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135819053?lang=zh_cn&edition=full","pubTime":"2024-11-06 17:48","pubTimestamp":1730886505,"startTime":"0","endTime":"0","summary":"医疗器械公司Globus Medical Inc.期周一股价盘前大涨12.46%,主因其第三季度业绩和全年预期均超出市场预期。财报显示,Globus Medical第三季度调整后每股收益为0.83美元,高于分析师预期的0.65美元。公司第三季度收入达到6.257亿美元,同比增长63.1%,也超过了分析师预测的6.0471亿美元。公司称,第三季度业绩出色主要得益于近期收购医疗器械公司NuVasive。凭借第三季度的出色表现,Globus Medical上调了2024财年的每股收益指引至2.90-3.00美元,高于此前指引2.80-2.90美元,也超过了华尔街2.85美元的共识预期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GMED"],"gpt_icon":0},{"id":"1135035860","title":"异动解读 | 医疗器械巨头Globus Medical第三季度业绩超预期 股价盘后大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1135035860","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135035860?lang=zh_cn&edition=full","pubTime":"2024-11-06 15:38","pubTimestamp":1730878725,"startTime":"0","endTime":"0","summary":"为全球骨骼肌肉健康解决方案领军者Globus Medical Inc.(纽约证券交易所代码:GMED)周一盘后股价大涨9.55%,主因其2024年第三季度财报超乎市场预期。\n\n财报显示,第三季度Globus Medical调整后每股收益为0.83美元,远高于分析师预期的0.65美元。公司营收达6.257亿美元,同比大增63.1%,也超过华尔街预测的6.0471亿美元。\n\n公司表示,业绩出色主要得益于收购竞争对手NuVasive公司、脊柱产品销量增长强劲,以及使能技术产品及服务销售表现亮眼。数据显示,报告期内Globus Medical在美国和国际市场的销售分别同比增长60.3%和74.8%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GMED"],"gpt_icon":0},{"id":"1158104370","title":"异动解读 | Globus Medical第三季度业绩超预期 全年指引上调 盘后股价大涨9.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=1158104370","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158104370?lang=zh_cn&edition=full","pubTime":"2024-11-06 15:08","pubTimestamp":1730876910,"startTime":"0","endTime":"0","summary":"医疗器械公司Globus Medical Inc.周一盘后股价大涨9.55%,主要得益于公司公布的2024年第三季度业绩及全年指引远超市场预期。据财报显示,Globus Medical第三季度调整后每股收益为0.83美元,高于分析师预期的0.65美元,也高于去年同期的0.57美元。公司第三季度收入达到6.257亿美元,同比增长63.1%,也超过了分析师预测的6.0471亿美元。凭借第三季度的出色表现,Globus Medical上调了2024财年的每股收益指引至2.90-3.00美元,高于此前的2.80-2.90美元预期,也超过了华尔街2.85美元的共识预期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GMED"],"gpt_icon":0},{"id":"1108039680","title":"异动解读 | Globus Medical 2024第三季度业绩超预期,股价盘后大涨 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1108039680","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108039680?lang=zh_cn&edition=full","pubTime":"2024-11-06 07:41","pubTimestamp":1730850070,"startTime":"0","endTime":"0","summary":"医疗器械公司Globus Medical Inc.(纽约证券交易所代码:GMED)周一(11月5日)盘后股价大涨9.55%,主要得益于公布的第三季度业绩和全年展望超出市场预期。\n\n财报显示,Globus Medical第三季度调整后每股收益为0.83美元,高于分析师预期的0.65美元。公司第三季度收入达到6.257亿美元,同比增长63.1%,也超过了分析师预测的6.0471亿美元。\n\n公司称,第三季度业绩出色主要得益于收购NuVasive公司,以及旗下脊柱产品销售和使能技术产品及服务销量的大幅增长。报告期内,美国市场净销售额同比增长60.3%,国际市场净销售额更是跃升74.8%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GMED"],"gpt_icon":0},{"id":"1197337465","title":"Globus Medical第三季度业绩强劲并上调指引,盘后股价上涨10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1197337465","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197337465?lang=zh_cn&edition=full","pubTime":"2024-11-06 07:36","pubTimestamp":1730849805,"startTime":"0","endTime":"0","summary":"肌肉骨骼解决方案公司 $Globus Medical Inc$ 的股价在报告第三季度盈利超出分析师预期并上调全年指引后跃升7.4%。\"我们的第三季度业绩反映了我们业务的持续强劲,\"总裁兼首席执行官Dan Scavilla表示。\"Globus Medical上调了2024财年的每股收益指引至2.90-3.00美元,高于此前的2.80-2.90美元预期,也超过了华尔街2.85美元的共识预期。公司全球净销售额的增长主要由NuVasive的加入推动,以及脊柱产品销售和使能技术产品及服务的销量增加。","market":"us","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Globus Medical第三季度业绩强劲并上调指引","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GMED"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.globusmedical.com","stockEarnings":[{"period":"1week","weight":-0.0423},{"period":"1month","weight":-0.0139},{"period":"3month","weight":-0.2137},{"period":"6month","weight":-0.0235},{"period":"1year","weight":0.3736},{"period":"ytd","weight":-0.1399}],"compareEarnings":[{"period":"1week","weight":-0.0419},{"period":"1month","weight":-0.0732},{"period":"3month","weight":-0.1115},{"period":"6month","weight":-0.1008},{"period":"1year","weight":0.0439},{"period":"ytd","weight":-0.1031}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Globus Medical, Inc.于2003年3月在特拉华州注册成立。作为一家医疗器械生产公司,Globus完全专注于其产品的设计、开发以及其商业化,其中这些产品能促进有脊柱疾病患者康复。Globus的产品分为两类,即创新融合类和颠覆性科技类。","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.028962},{"month":2,"riseRate":0.692308,"avgChangeRate":-0.006941},{"month":3,"riseRate":0.538462,"avgChangeRate":0.010327},{"month":4,"riseRate":0.538462,"avgChangeRate":0.001833},{"month":5,"riseRate":0.583333,"avgChangeRate":0.034506},{"month":6,"riseRate":0.5,"avgChangeRate":0.007654},{"month":7,"riseRate":0.666667,"avgChangeRate":0.016568},{"month":8,"riseRate":0.583333,"avgChangeRate":-0.00365},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.01551},{"month":10,"riseRate":0.692308,"avgChangeRate":0.030902},{"month":11,"riseRate":0.615385,"avgChangeRate":0.030641},{"month":12,"riseRate":0.769231,"avgChangeRate":0.035812}],"exchange":"NYSE","name":"Globus Medical Inc","nameEN":"Globus Medical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Globus Medical Inc(GMED)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Globus Medical Inc(GMED)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Globus Medical Inc,GMED,Globus Medical Inc股票,Globus Medical Inc股票老虎,Globus Medical Inc股票老虎国际,Globus Medical Inc行情,Globus Medical Inc股票行情,Globus Medical Inc股价,Globus Medical Inc股市,Globus Medical Inc股票价格,Globus Medical Inc股票交易,Globus Medical Inc股票购买,Globus Medical Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Globus Medical Inc(GMED)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Globus Medical Inc(GMED)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}